CANLI
Yükleniyor Veriler getiriliyor…
SCI-Expanded JCR Q3 Özgün Makale Scopus
Synthesis of Silica Based Nanoparticles Against the Proliferation of Human Prostate Cancer
Anti-Cancer Agents in Medicinal Chemistry 2021 Cilt 21 Sayı 18
Scopus Eşleşmesi Bulundu
5
Atıf
21
Cilt
2553-2562
Sayfa
Özet
Background: Prostate cancer (PCa) has the second-highest morbidity and mortality rates in men. Possessing facile surface chemistry and unique optical properties make silica nanoparticles(SiO2-NPs) promis-ing cancer therapy materials. Objective: This study aimed to investigate the effects of SiO2-NPs and their derivatives, including SiNP-NH2, SiNP-Cl, and SiNP-SH against PCa and clarify their molecular mechanism on cell death, gene, and protein ex-pressions. Methods: Following the synthesis and derivation of SiO2-NPs, their characterization was carried out using TEM, DLS, BET, and FT-IR. Cytotoxic properties of the compounds were investigated against different human cancerous cells; including HUH-7, A549, DLD-1, HeLa, NCI-H295R, and PC-3, as well as human healthy epithelium cell line PNT1A. Results: SiNP-NH2, SiNP-Cl, and SiNP-SH dose-dependently inhibited the proliferation of PC-3 cells with an IC50 value as 55.46 μg/mL, 55.09 μg/mL and 72.89 μg/mL, respectively. SiNP-SH significantly(p<0.0001) inhibited metastasis and invasion of PC-3 cells(20.4% and 46.7%, respectively), and significantly(p<0.0001) increased early apoptosis(32.3%) when compared with non-treated cells. Protein and mRNA expressions of BcL-2, Bax, caspase-3, caspase-9, caspase-12, p53, Smad-4, Kras, and Nf-ĸB were also altered following the treatment of SiO2-NPs and its derivatives. Conclusion: Our results demonstrated that-SH functioned SiO2-NPs can prevent the proliferation of human PCa by increasing apoptosis by up-regulating gene and protein expression of p53(TP53) as well as caspase-3, caspase-9, and caspase-12 in the apoptotic pathway. Besides, the increased level of Smad-4 has also implicated the decreased cell proliferation. Hence, low sized SiNP-SH nanoparticles might be a suitable candidate for the treatment of human PCa.
Web of Science Eşleşmesi Bulundu
5
WoS Atıf
21
Cilt
Article
Belge Türü
Kaynak: ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY · s. 2553-2562
Anahtar Kelimeler (WoS)

Havuzumuzdaki Atıflar 0

Bu makaleye, sistemimizdeki Scopus veritabanında bulunan 0 makale atıf yapmıştır. Scopus genel atıf sayısı: 5.

Bu makaleye, kendi Scopus havuzumuzdaki başka bir makaleden atıf kaydı bulunmuyor.
Scimago Dergi Bilgisi Otomatik ISSN Eşleştirmesi 2021 yılı verileri
Anti-Cancer Agents in Medicinal Chemistry
Q3
SJR Quartile
0,403
SJR Skoru
113
H-Index
Kategoriler: Molecular Medicine (Q3) · Pharmacology (Q3) · Cancer Research (Q4)
Alanlar: Biochemistry, Genetics and Molecular Biology · Pharmacology, Toxicology and Pharmaceutics
Ülke: United Arab Emirates · Bentham Science Publishers
Bu bilgiler makale yılına göre Scimago veritabanından ISSN eşleştirmesiyle otomatik getirilmektedir. Dergi sıralama verileri Scimago'nun ilgili yılı baz alınmaktadır.

Anahtar Kelimeler

WoS | Bir kelimeye tıklayıp ilgili kaynaktaki yayınları görün.

Makale Bilgileri

Dergi Anti-Cancer Agents in Medicinal Chemistry
ISSN 1871-5206
Yıl 2021 / 12. ay
Cilt / Sayı 21 / 18
Sayfalar 2553 – 2562
Makale Türü Özgün Makale
Hakemlik Hakemli
Endeks SCI-Expanded
JCR Quartile Q3
Teşvik Puanı 5,40 · YÖKSİS Akademik Teşvik
Yayın Dili İngilizce
Kapsam Uluslararası
Toplam Yazar 3 kişi
Erişim Türü Basılı+Elektronik
Alan Fen Bilimleri ve Matematik Temel Alanı Kimya Fiziksel Kimya Yüzey Kimyası

YÖKSİS Yazar Kaydı

Yazar Adı DURMUŞ İREM MUKADDES, DEVECİ İLYAS, KARAKURT SERDAR
YÖKSİS ID 5644301

Metrikler

Scopus Atıf 5
Havuz Atıfları 0
JCR Quartile Q3
Teşvik Puanı 5,40
Yazar Sayısı 3